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Molecular, Universidad de Valencia, Burjassot, Valencia, SpainABSTRACT Recent data suggest that a functional cooperation between surfactant proteins SP-B and SP-Cmay be required to
sustain a proper compression-expansion dynamics in the presence of physiological proportions of cholesterol. SP-C is a dually
palmitoylated polypeptide of 4.2 kDa, but the role of acylation in SP-C activity is not completely understood. In this work we have
compared the behavior of native palmitoylated SP-C and recombinant nonpalmitoylated versions of SP-C produced in bacteria
to get a detailed insight into the importance of the palmitic chains to optimize interfacial performance of cholesterol-containing
surfactant films. We found that palmitoylation of SP-C is not essential for the protein to promote rapid interfacial adsorption of
phospholipids to equilibrium surface tensions (~22 mN/m), in the presence or absence of cholesterol. However, palmitoylation of
SP-C is critical for cholesterol-containing films to reach surface tensions%1mN/m at the highest compression rates assessed in
a captive bubble surfactometer, in the presence of SP-B. Interestingly, the ability of SP-C to facilitate reinsertion of phospholipids
during expansion was not impaired to the same extent in the absence of palmitoylation, suggesting the existence of palmitoy-
lation-dependent and -independent functions of the protein. We conclude that palmitoylation is key for the functional cooperation
of SP-C with SP-B that enables cholesterol-containing surfactant films to reach very low tensions under compression, which
could be particularly important in the design of clinical surfactants destined to replacement therapies in pathologies such as
acute respiratory distress syndrome.INTRODUCTIONBreathing and lung mechanics critically depend on a great
variety of lipid/lipid and lipid/protein interactions that occur
in pulmonary surfactant, a lipid/protein complex that lines
the inner surface of the lungand functions to reduce the surface
tension at the air/liquid interface in order tominimize thework
of breathing (1,2). The lack or dysfunction of an active surfac-
tant results in severe respiratory disorders, such as neonatal
respiratory distress syndrome or acute respiratory distress
syndrome (ARDS) associated with lung injury (3).
In order to fulfill its function, pulmonary surfactant has
been evolutionarily optimized to contain ~80–85% of phos-
pholipids, with approximately one-half of them being DPPC
(dipalmitoylphosphatidylcholine), 5–10% neutral lipids,
mainly cholesterol, and 6–8% specific surfactant-associated
proteins. DPPC, the major lipid species in lung surfactant,
and the two small hydrophobic surfactant proteins SP-B
and SP-C have emerged as the most critical components
for a functional surfactant (2). DPPC is absolutely necessary
for surfactant films to reach very low surface tensions
(%1 mN/m) upon compression. On the other hand, SP-B
and SP-C have been shown to be required for efficient inter-
facial adsorption, film stability, and respreading of the
surfactant film upon expansion (4). The combination of
these properties is pivotal for the dynamic behavior ofSubmitted February 7, 2010, and accepted for publication August 31, 2010.
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expansion throughout breathing in vivo (5).
SP-C is the smallest of the surfactant-associated proteins.
Mature SP-C consists of a C-terminal, very hydrophobic
a-helix and a dually palmitoylated N-terminal segment (6).
Although SP-C is not absolutely critical for survival, SP-C
(/) mice develop progressive pneumonitis of different
degrees depending on the genetic background (7). In vitro
data indicate that SP-C is required to maintain surfactant
reservoirs attached to the interface during states of high
compression, at the end of expiration (8). These reservoirs
could then reinsert rapidly under the critical participation
of SP-B. The palmitoylation of SP-C has been proposed to
be important for the stabilization of the reservoirs (9,10).
Despite the presence of 5–10%by totalmass of cholesterol
in pulmonary surfactant, cholesterol has been regarded as
detrimental for proper lung function. In vitro data suggest
severe structural changes in surfactant films in the presence
of high concentrations (20%) of cholesterol (11), and clinical
surfactant substitutes do not usually contain cholesterol (12).
Furthermore, the presence of exacerbated levels of choles-
terol has been implicated in the pathology ofARDS and other
diseases (13). Nevertheless, cholesterol has been shown to
modulate molecular dynamics of phospholipids in surfactant
complexes (14). In fact, cholesterol levels in surfactant are
tightly controlled and are regulated in some species in
response to temperature changes (15). Recent reports have
shown that SP-B and SP-C can cooperate to counteract thedoi: 10.1016/j.bpj.2010.08.070
Acylation of SP-C in Surfactant Films 3235deleterious effects of cholesterol on surfactant film stability
during continuous cycling (16).
In this article, we investigate the role of palmitoylation of
SP-C for the cooperation with SP-B to stabilize cholesterol-
containing surfactant films subjected to compression/expan-
sion dynamics in a captive bubble surfactometer (CBS). By
comparing native palmitoylated SP-C with recombinant
(nonpalmitoylated) versions of the protein, we show that
the presence of the palmitic chains is critical for SP-C to
cooperate with SP-B in this function. The present data,
therefore, refine the concept of how SP-B and SP-C might
cooperate in vivo to enable proper functioning of choles-
terol-containing pulmonary surfactant.MATERIALS AND METHODS
Reagents
DPPC, (1,2-dipalmitoyl-sn-glycero-3-phosphocholine), POPC (1-palmi-
toyl-2-oleoyl-sn-glycero-3-phosphocholine), POPG (1-palmitoyl-2-oleoyl-
sn-glycero-3[phospho-rac-(1-glycerol)]), and cholesterol were all from
Avanti Polar Lipids (Alabaster, AL). Chloroform and methanol solvents,
HPLC grade, were from Scharlau (Barcelona, Spain). Native surfactant
proteins SP-B and SP-C were isolated from minced porcine lungs as
described elsewhere (17).
Recombinant protein purification
For the production of different recombinant SP-C versions, we essentially
followed the procedures described by Lukovic et al. (18). Recombinant
protein quality was controlled by sodium dodecyl sulfate-polyacrylamide
gel electrophoresis, mass spectrometry and amino-acid analysis. Table S1
in the Supporting Material summarizes and compares the sequences of the
produced proteins.Due to the purification procedures that involve a thrombin
digestion at an optimized cleavage site to yield recombinant SP-C from the
fusion protein, most of the recombinant SP-C variants used here contain an
N-terminal GP extension. Previously, we had not found significant structural
or functional differences between recombinant forms bearing or not bearing
these extensions (18). Nevertheless, some of the experiments shown in this
studywere also repeatedwith SP-Cversions that do not contain theGP exten-
sion, and their behavior was again found to be completely comparable, as it
will be described. Because final protein yield is much higher for the GP-con-
taining SP-C versions, unless otherwise stated the recombinant protein used
in the experiments was produced with this dipeptide-extension.
Reconstitution of lipid and lipid/protein samples
The standard lipid mixture used in this study to reconstitute pulmonary
surfactant model suspensions contained DPPC/POPC/POPG (50:25:15,
w/w/w). This mixture simulates the proportion of saturated/unsaturated
and zwitterionic/anionic phospholipids in surfactant. When indicated, the
samples contained 5% cholesterol to mimic the physiological surfactant
composition. Multilamellar suspensions were prepared by mixing the
appropriate amount of protein and lipids in chloroform/methanol 2:1,
drying the samples overnight under vacuum, and resuspending them at
45C in the desired final volume of sample buffer (5 mM Tris,150 mM
HCl buffer, pH 7.0) for 1.5 h and shaking. The lipid suspensions were
generally prepared at a final concentration of 10 mg/mL.
Captive bubble surfactometry
The surface activity of the model surfactant mixtures was assessed in
a computer-controlled captive bubble surfactometer (CBS) operated asdescribed previously (16). This device, described in detail elsewhere
(19,20), allows a reliable and reproducible estimation of the surface tension
of surfactant films subjected to compression/expansion dynamics. The CBS
chamber, thermostated at 37C, was filled with ~1.5 mL of sample buffer
(5 mM Tris, 150 mM NaCl, pH 7.0) containing 10% w/w sucrose (Sigma,
St. Louis, MO), in order to increase its density, and contained originally no
surfactant. Then the surfactant sample was accurately measured and in-
jected, using a micropositioning device, at the proximity of the bubble
surface. The high density of the bulk solution induces surfactant suspen-
sions to float and remain in close contact with the bubble upon injection
(see Fig. S1). The presence of sucrose does not affect surface activity of
surfactant (21).
A small air bubble (~2 mm in diameter, 50 mL) was introduced into the
chamber after degassing the buffer solution and allowed to float up to the
agarose ceiling. Then, ~0.5 mL of lipid or lipid/protein surfactant suspen-
sion (10 mg/mL) were deposited directly at the air/buffer interface of the
bubble by means of a transparent capillary. The bubble was imaged with
a video camera (Pulnix TM 7 CN; JAI-PULNiX, Glostrup, Denmark) and
recorded for later analysis. A 5-min adsorption (film formation) period fol-
lowed the introduction of the surfactant model suspensions into the
chamber, during which the bubble was not manipulated and the change in
surface tension was monitored (initial adsorption). The chamber was then
sealed and the bubble was rapidly (1 s) expanded to a volume of 0.15 mL
and changes in surface tension were monitored during 5 min (postexpansion
adsorption). Because the size of the bubble is increased significantly, post-
expansion adsorption also evaluates how efficiently a surplus of surfactant
has maintained association with the interface, after initial injection, to refill
the new opening surface. Then, quasistatic cycling was initiated, where the
bubble size was first reduced and then enlarged in a stepwise fashion.
Each step had two components: a 3 s change in volume followed by a 4 s
delay where the chamber volume remained unchanged and the film was
allowed to equilibrate. Under these conditions, interfacial structures could
relax along the compression-expansion isotherms. Compression was always
stopped when minimum surface tension was obtained, before the collapse
of the film would lead to a variable level of overcompression. The collapse
point at which overcompression can be prevented was judged visually,
when the height of the bubble does not change upon further compression
but the bubble shrinks in diameter instead. In the dynamic cycles, the
bubble size was continuously compressed and expanded over the same
volume range as during the quasistatic cycles for 20 cycles at a rate of
20 cycles/min (roughly in the range of the respiration rate of the lung).
For all imaged bubbles, volume, interfacial area, and surface tension
were calculated using height and diameter of the bubble as previously
described (16,22). Fig. S2 compares the waveform of area and volume
oscillations under quasistatic and dynamic conditions. At least four inde-
pendent experiments were performed for each surfactant model suspension,
using at least two different batches of purified protein, with qualitatively
comparable results. Data from adsorption experiments are presented as
means 5 SD. Compression-expansion isotherms are representative
experiments.RESULTS
To get new insights into the role of palmitoylation in SP-C,
we compared native palmitoylated SP-C purified from
porcine lungs with two different recombinant versions of
SP-C that were produced in Escherichia coli. One of them
reflects the wild-type sequence of human mature SP-C.
Because bacteria lack the mammalian palmitoylation
machinery, this recombinant SP-C form (i.e., rSP-C CC)
displays two free cysteines at positions 5 and 6 of the
sequence (Table S1). Mass spectrometry and electrophoretic
analysis confirm that this protein stably maintains theBiophysical Journal 99(10) 3234–3243
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the periods of time in which our experiments were carried
out. The other recombinant SP-C variant studied contained
two phenylalanine residues substituting for the cysteines
(i.e., rSP-C FF). The rationale for choosing this replacement
was that in several animals, one of the two cysteines in SP-C
is substituted by phenylalanine (23). rSPC FF has therefore
been proposed as a potentially functional equivalent to wild-
type SP-C in clinical preparations.
In a first series of experiments, we investigated how pal-
mitoylation could affect the surface activity of the protein.
To this end, we analyzed the behavior in a CBS of DPPC/
POPC/POPG (50:25:15, w/w/w) suspensions containing
5% cholesterol or not, in the absence or presence of 1% of
native or recombinant SP-Cs. Fig. 1 shows the time-depen-
dent reduction of surface tension upon adsorption of the
different lipid or lipid/protein samples at the air-liquid inter-
face of an air bubble (initial adsorption) or after expansion
of the bubble (adsorption postexpansion). Initial adsorption
includes association of injected complexes to the bubble
surface and transfer of surface active molecules into the
interface. Postexpansion adsorption to a bubble which has
been considerably enlarged also evaluates the ability
of the surplus of surfactant initially injected to formFIGURE 1 Initial and postexpansion adsorption in the presence of SP-C.
The effect of native and recombinant SP-C on the interfacial adsorption
kinetics of lipid suspensions composed of DPPC/POPC/POPG (50:25:15,
w/w/w) was measured in the absence (upper panels) or presence (lower
panels) of 5% w/w cholesterol. (Left) Decrease of surface tension over
time during the first 5 min after deposition of ~0.5 mL of the different lipid
or lipid/protein samples (10 mg/mL). (Right) Decrease in surface tension
monitored during 5 min after expansion of the bubble from a volume of
~0.045–0.15 mL. Data are means 5 SD after averaging data from three
independent experiments.
Biophysical Journal 99(10) 3234–3243a surface-associated reservoir ready to refill the newly
open interface.
In the absence of protein, purely lipidic suspensions
showed very limited interfacial adsorption to equilibrium
tensions that were barely lower than 55 mN/m, regardless
of the presence of cholesterol. In contrast, for samples con-
taining 2% of any of the SP-C forms exhibited, in the
absence of cholesterol there was an almost instantaneous
drop of surface tension to below 30 mN/m. Palmitoylation,
therefore, does not seem to be required for SP-C to promote
efficient interfacial adsorption in the absence of cholesterol.
Surprisingly though, in the presence of 5% cholesterol,
while samples containing palmitoylated SP-C still reached
low tensions both right after sample deposition and after
expansion, samples with rSP-C CC produced much less
surface tension reduction. rSPC FF behaved similar to
native SP-C, although the reduction in surface tension at
initial adsorptions was somewhat slower. rSP-C CC per-
formed worse both in initial and postexpansion adsorption,
producing tensions not lower than ~40 mN/m. This would
indicate that, in the presence of cholesterol, phenylalanines
are able to mimic to a certain degree the effects of the pal-
mitic chains in their role in adsorption, while the free cyste-
ines are not.
Fig. 2 shows quasistatic cycling of surfactant films con-
taining native or recombinant SP-C as the single protein
component, in the presence or absence of cholesterol.
Controls were performed with pure lipid films. In the
absence of any protein, surfactant films cannot reach upon
compression surface tensions lower than the equilibrium
tension of ~22 mN/m and show a very high maximum
surface tension, indicating that the material is not efficiently
respreading into the interface upon expansion. In the
absence of cholesterol, 2% of native SP-C was sufficient
to allow the films reaching tensions close to 0 mN/m with
efficient respreading (Fig. 2, upper panels), as revealed by
the low maximal tensions. However, considerable compres-
sion/expansion hysteresis, especially during the first two
cycles, reflects low stability of the compressed phases.
Furthermore, a pronounced plateau at ~20 mN/m is
clearly visible before the compressed film reaches the
lowest surface tensions. This plateau has been associated
with compression-driven three-dimensional transitions,
likely facilitated by SP-C, taking the film to configurations
able to support the maximal surface pressures (minimal
tensions) without collapsing (24). In this respect, recombi-
nant versions of SP-C reproduce only partly the behavior
of native SP-C. Samples containing rSP-C CC produce
lower minimal tensions than pure lipidic samples but do
not reach as low values as the samples containing native pal-
mitoylated protein. This recombinant SP-C produced also
maximal tensions that were intermediate between those
reached by pure lipid and the low maximal tensions main-
tained by the native protein. The rSP-C FF variant, on the
other hand, displays a behavior somehow closer to the native
FIGURE 2 Quasistatic compression/expansion isotherms in the presence of SP-C. Films formed from DPPC/POPC/POPG (50:25:15, w/w/w) suspensions
in the absence (upper panels) or presence (lower panels) of 5% (w/w) cholesterol and containing no protein (left), or 2% (w/w) of native SP-C (central left),
rSP-C CC (central right), or SP-C FF (right) were subjected to quasistatic cycling. The surface-tension-versus-relative-area is plotted for the four consecutive
stepwise compression-expansion isotherms.
Acylation of SP-C in Surfactant Films 3237palmitoylated protein, as it allows reaching the lowest
surface tensions while respreading is still impaired.
In the presence of cholesterol, none of the SP-C versions
tested could lead by themselves to a substantial reduction in
surface tension upon compression compared to pure lipid
films. Presence of the protein led to the appearance of large
compression plateaus, at ~20 mN/m, which did not progress
to a further reduction in tension, as observed in the absence
of cholesterol (Fig. 2, bottom panels). The fluidizing effect
of cholesterol may prevent compression of the surfactant
film to states compatible with further reduction of surface
tension. It is noteworthy that native palmitoylated SP-C is
significantly more efficient in promoting respreading of
the films upon expansion also in the presence of cholesterol,
as can be seen in the considerably lower maximum surface
tension reached in the presence of native SP-C.
Fig. 3 shows dynamic cycling (at 20 cycles/min) of the
same surfactant films described in Fig. 2. In the absence of
cholesterol, all the films containing proteinwere able to reach
very low surface tensions, irrespective of the SP-C version
used (Fig. 3, upper panels). The rapid compression/expan-
sion rate used during dynamic cycling probably prevents
reorganization of the film such as occurs upon the stepwise
compression and expansion applied in quasistatic cycles.
This effect may explain why some films are able to reachlower tensions during rapid dynamic cycling than under qua-
sistatic conditions. A kinetic effect is probably also associ-
ated with differences in the reinsertion of lipids upon
reexpansion. During rapid cycling there is not enough time
for reinsertion, increasing the differences between proteins
that promote respreading with different efficacies. Maximal
tensions are higher for films cycled under dynamic condi-
tions, with only native SP-C reducing significantly the
maximal tension in the absence of cholesterol. Cholesterol
has again a general impairing effect on the ability of the films
to reach low surface tension during dynamic cycling, irre-
spective of the presence of SP-C (Fig. 3, bottom panels).
Previous work of our group revealed a cooperative effect
of SP-B and SP-C that could alleviate the deleterious effects
of cholesterol on the surface activity of surfactant films (16).
We therefore wanted to explore whether recombinant
versions of SP-C could mimic native SP-C in this effect.
First, we compared the behavior of samples containing
1% w/w SP-B as the only protein component, in the pres-
ence or absence of 5% w/w cholesterol. Measurements of
initial and postexpansion adsorption showed that cholesterol
impaired the ability of these samples to rapidly reach low
surface tensions as compared to the samples that did not
contain cholesterol (Fig. 4). Inclusion of 2% (w/w) of
SP-C, however, improved adsorption in the presence ofBiophysical Journal 99(10) 3234–3243
FIGURE 3 Dynamic compression-expansion isotherms in the presence of SP-C. Films formed from DPPC/POPC/POPG (50:25:15, w/w/w) suspensions in
the absence (upper panels) or presence (lower panels) of 5% (w/w) cholesterol and containing no protein (left), or 2% (w/w) of native SP-C (central left),
rSP-C CC (central right), or rSP-C FF (right) were subjected to dynamic cycling at a rate of 20 cycles/min. The surface-tension-versus-relative-area is plotted
for the first, 10th, and 20th cycle of continuous compression-expansion isotherms.
3238 Baumgart et al.cholesterol significantly, as shown in Fig. 4, independently
of the form of SP-C used. While recombinant nonpalmitoy-
lated SP-C is indistinguishable from native palmitoylatedFIGURE 4 Initial and postexpansion adsorption in the presence of
cholesterol, SP-B, and SP-C. The effect of native and recombinant SP-C
on the interfacial adsorption kinetics of lipid suspensions composed of
DPPC/POPC/POPG (50:25:15:10, w/w/w) plus 1% (w/w) porcine SP-B
was evaluated in the presence of 5% w/w cholesterol. (Left panel) Initial
adsorption (recorded during 5 min after deposition of the respective lipid
samples. (Right panel) Postexpansion adsorption(decrease in surface
tension during 5 min after expansion of the bubble to a volume of
0.15 mL. The samples, with 1% (w/w) of SP-B, contained no cholesterol,
5% (w/w) cholesterol, or 5% (w/w) cholesterol plus 2% (w/w) native
SP-C, rSP-C CC, or rSP-C FF. Data are means 5 SD after averaging
data from three independent experiments.
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of cholesterol, clear differences became apparent when the
surfactant films were subjected to quasistatic or dynamic
compression/expansion cycling. Quasistatic cycles of films
containing 5% (w/w) cholesterol, 1% (w/w) of native
SP-B, and 2% (w/w) of either native or recombinant SP-C
are shown in Fig. 5. Cholesterol drastically impairs the
ability of SP-B-containing surfactant films to reach very
low surface tensions upon compression.
Strikingly, the presence of palmitoylated SP-C counter-
acts this deleterious effect of cholesterol (Fig. 5, left panel),
confirming recently published results (16). In contrast,
cholesterol-containing films including nonpalmitoylated re-
combinant forms of SP-C are unable to reach surface
tensions below ~20mN/m. Interestingly, the ability of
SP-C to facilitate respreading of the films upon expansion,
as can be inferred from the maximum surface tensions
reached upon cycling, is retained in the presence of nonpal-
mitoylated SP-C, both in the case of rSP-C CC and rSP-C
FF. The palmitic chains therefore do not seem to be relevant
for this function of SP-C, at least in the presence of SP-B
(see Discussion). Note that rSP-C FF is slightly more effi-
cient in lowering the maximum surface tension, supporting
the role of the phenylalanines in partly mimicking the
palmitoylcysteines.
FIGURE 5 Quasistatic cycling and SP-B/SP-C cooperation in choles-
terol-containing surfactant films. Films formed from DPPC/POPC/POPG
(50:25:15, w/w/w) suspensions containing 1%w/w SP-B and no cholesterol
(top left) or containing 5% (w/w) cholesterol (right panels) were subjected
to quasistatic cycling in the absence of SP-C (top), or in the presence of
2% (w/w) of native SP-C (upper center), rSP-C CC (lower center), or
SP-C FF (bottom). The surface-tension-versus-relative-area is plotted for
the first, second, third, and fourth cycle of four consecutive stepwise
compression-expansion isotherms.
FIGURE 6 Dynamic cycling and SP-B/SP-C cooperation in cholesterol-
containing surfactant films. Films formed from DPPC/POPC/POPG
(50:25:15, w/w/w) suspensions containing 1%w/w SP-B and no cholesterol
(top left) or containing 5% (w/w) cholesterol (right panels) were subjected to
dynamic cycling in the absence of SP-C (top), or in the presence of 2% (w/w)
of native SP-C (upper center), rSP-C CC (lower center), or rSP-C FF
(bottom).The surface-tension-versus-relative-area is plotted for the first,
10th, and 20th cycle of continuous compression-expansion isotherms.
Acylation of SP-C in Surfactant Films 3239Fig. 6 shows dynamic cycling of the same surfactant films
as in the quasistatic cycles shown in Fig. 5. Native SP-C is
very efficient to cooperate with SP-B in lowering surface
tension uponminimal compression in the presence of choles-
terol, while producing compression-expansion isotherms
with very little hysteresis and very low maximum surface
tension. On the other side, films containing cholesterol and
nonpalmitoylated rSP-C CC reach rapidly 20 mN/m upon
compression but do not progress further to lower pressures,presumably because in the absence of palmitoylation the
protein is not efficient in preventing relaxation of the fluid
cholesterol-containing films upon compression. Interest-
ingly, rSP-C FF is able to mimic the behavior of the native
protein to some extent but only in the first cycle. The phenyl
rings can probably support some anchoring of SP-C, but not
to the same degree as the palmitoyl groups that are able to
penetrate deep into the films. It should be noted that dynamic
cycling isotherms of films containing rSP-C FF showed
a certain variance, in some cases being even more similarBiophysical Journal 99(10) 3234–3243
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(see Fig. S3 showing four independent experiments).
As a complementary control, we also performed cycling
experiments with films simultaneously containing SP-B
and one of the different forms of SP-C, but in the absence
of cholesterol (Fig. S4). Both the quasistatic and the
dynamic behavior of lipid films containing SP-B and native
palmitoylated SP-C resembled the results shown in Figs. 5
and 6, obtained in the presence of cholesterol, which were
characterized by minimal surface tensions close to
0 mN/m attained with low compression rates (%20%), little
compression-expansion hysteresis and low maximum
tensions. In the absence of cholesterol, however, we could
also observe a different effect of the recombinant versions
of SP-C on the behavior of the lipid films during quasistatic
and dynamic cycling.
As shown in the four lower panels of Fig. S4, the interfa-
cial films containing recombinant proteins were also able to
reach very low surface tensions, just like in the presence of
the native protein. Especially in dynamic cycles, though,
considerable differences could be observed in terms of
hysteresis and maximum surface tensions, which were
both significantly impaired in the presence of recombinant
SP-C forms compared with the behavior of films containing
the palmitoylated native version of SP-C. These results
suggest that in films containing the recombinant proteins
that lack palmitic chains, and despite the presence of
SP-B, some of the material that is excluded during compres-
sion is not efficiently respread when cycling is fast.
To discard that the inefficiency of the recombinant SP-C
forms to mimic the behavior of native SP-C could be due to
the N-terminal dipeptide extension of all the recombinant
protein versions studied, we produced a recombinant SP-C
bearing phenylalanines and lacking the GP extension (see
compared sequences in Table S1). As summarized in the
Fig. S5, the behavior of this variant lacking the GP exten-
sion was completely analogous to that of the rSP-C FF
form so far described. It restores interfacial adsorption of
SP-B-containing samples in the presence of cholesterol,
and maintains good respreading properties during film
expansion, while it was inefficient to restore the ability of
the films to produce low enough surface tension upon
compression.
To check whether the differences detected in surface
behavior between native and recombinant forms of SP-C
could be still due to structural differences of the proteins
once reconstituted in membranes, we carried out a confor-
mational analysis of the proteins in the two lipid systems
studied, by means of far-ultraviolet circular dichroism
(CD) spectroscopy. Fig. S6 compares the CD spectra of
SP-C and rSP-C reconstituted in DPPC/POPC/POPG
membranes in the absence or presence of 5% cholesterol.
CD spectra were consistent with a mainly a-helical confor-
mation of the two proteins in the two studied environments,
discarding that production/manipulation of the proteins hadBiophysical Journal 99(10) 3234–3243shifted the typical helical conformation of SP-C toward
b-sheet aggregates (25).
Interestingly, the presence of cholesterol slightly increased
the negative ellipticity of the CD spectra of the two proteins,
which can be indicative of an increase/stabilization of theira-
helical content. Determination, from the CD spectra, of the
content of the different types of secondary structure (see
Table S2) revealed that native SP-C had 58 5 2% and
6151%a-helix in the absence and in the presence of choles-
terol, respectively, while rSP-C contains 615 3% a-helix in
the absence of cholesterol and 70 5 5% in its presence.
Differences in helicity between the two proteins, in the
absence or in the presence of cholesterol, are not significant.
However, the presence of cholesterol seems to introduce
a consistent similar trend toward an increase in helical
content in the two proteins, as it was recently revealed for
the native protein using Fourier transform infrared spectro-
scopy (26).DISCUSSION
The role of cholesterol in pulmonary surfactant has re-
mained elusive, and is vigorously debated. In native pulmo-
nary surfactant, cholesterol is critical to sustain segregation
of fluid-ordered and fluid-disordered phases and it influ-
ences phospholipid mobility and dynamics (14) with
possible consequences for surfactant film stability. Although
surfactant films must be rigid enough to support high surface
pressures, they must also be sufficiently dynamic to cope
with the continuous compression/expansion cycles that
occur during breathing. While the high content in saturated
lipids (mainly DPPC) is pivotal for the mechanical stability
of pulmonary surfactant, cholesterol could improve the
dynamic behavior of the lipid films. In heterothermic
animals, the proportion of cholesterol in pulmonary surfac-
tant increases when the body temperature decreases, high-
lighting its physiological importance (15). Nevertheless,
cholesterol is considered detrimental to surfactant function
based on in vitro data, where it impairs the surface activity
of surfactant films (27). An exacerbated proportion of
cholesterol in surfactant has been associated with ARDS
(13), a condition with a fatality of 30–40%, and with an inci-
dence of 150,000 cases per year in the US. For these
reasons, cholesterol is removed from all clinically used
surfactants (12).
Recent data suggest that SP-C could have an important role
to sustain surfactant function in the presence of cholesterol
(16). In most animals SP-C is dually palmitoylated at
cysteine residues 5 and 6. Protein palmitoylation has been re-
ported to promote interaction of some proteins with choles-
terol-enriched raftlike domains in membranes (28). We
therefore wondered whether palmitoylation could also be
essential for SP-C to interact with cholesterol-rich lipid
domains and so to promote stability of cholesterol-contain-
ing surfactant films under compression/expansion dynamics.
Acylation of SP-C in Surfactant Films 3241Previously, palmitoylation of SP-C had been primarily linked
to the structural integrity of mature SP-C (29), but also to
a role in maintaining the mechanical stability of surfactant
films (9,10). These studies, however, relied onmodel systems
that did not include cholesterol and varied greatly in the sour-
ces of SP-C and the methods of analysis.
Our data indicate that, in cholesterol-free systems, palmi-
toylation of SP-C is not essential to promote interfacial
adsorption of phospholipids, an activity strictly required to
facilitate formation and reextension of surface active films.
These results agree with previous data showing that, under
equilibrium conditions, deacylated SP-C is equally active
in facilitating the insertion of phospholipids into interfacial
films (9,10). In contrast, in the presence of cholesterol, pal-
mitoylated SP-C showed clearly better interfacial adsorp-
tion capabilities than the nonpalmitoylated recombinant
protein, an activity that could be mimicked by replacing pal-
mitoylated cysteines with phenylalanines. During compres-
sion/expansion cycles, the lack of palmitoylation resulted in
an increased maximum surface tension and a reduced ability
of the films to reach very low surface tensions, particularly
in the quasistatic regime. These results illustrate why
a synthetic surfactant preparation containing recombinant
SP-C as the single protein additive could be efficient enough
to be useful in respiratory therapies (30), particularly if
using SP-C forms bearing phenylalanines, in lipid mixtures
lacking cholesterol.
The differences between native and recombinant SP-C in
equilibrium adsorption that were seen in the presence of
cholesterol were not observed when SP-B was also present
in the surfactant samples (seen in Fig. 4). Therefore, pal-
mitic chains are apparently not essential for SP-C to coop-
erate with SP-B in promoting interfacial adsorption of
cholesterol-containing lipid-protein samples. On the other
hand, native palmitoylated SP-C counteracts the deleterious
effects of cholesterol in cycling dynamics of SP-B-contain-
ing films. In the absence of palmitic chains, however, re-
combinant SP-C forms are not completely efficient in
preventing the negative effects of cholesterol. Still, the re-
combinant versions of SP-C are able to fulfill some func-
tions in cooperation with SP-B. Fig. 5 shows how both
recombinant versions of SP-C can limit maximum surface
tensions to values very similar to those obtained for native
SP-C, although they are unable to improve minimum
surface tensions. We conclude that the reinsertion of phos-
pholipids into the lipid film during expansion that is facili-
tated by SP-C does not depend on the palmitic chains
when SP-B is also present.
A last remarkable feature revealed by our results is that
recombinant forms of SP-C, but not the native palmitoylated
protein, could somehow affect negatively the activity of
SP-B. Incorporation of native SP-C does not essentially
affect the behavior of SP-B-containing films subjected to
quasistatic or dynamic compression-expansion cycling
(compare upper panels in Fig. S5 with the left panel inFigs. 5 and 6). However, incorporation of the two recombi-
nant SP-C forms tested here impairs substantially the
compression/expansion dynamics of SP-B-containing films,
which behave practically as in the absence of SP-B
(compare Fig. S5 with the upper panels in Fig. 3). The
design and production of future surfactant preparations
that could combine analogs of both SP-B and SP-C will
require a detailed study confirming that the analogs of the
two proteins do really cooperate and are not actually coun-
teracting under physiologically meaningful dynamic
constraints.
Differences in activity of native palmitoylated and non-
palmitoylated recombinant SP-C forms are not due to differ-
ences in the conformation of the proteins, as confirmed by
CD spectroscopy. Both proteins have a similar a-helical
conformation, and they both are similarly influenced by
the presence of cholesterol. As it was also determined for
native SP-C by using Fourier transform infrared spectro-
scopy (26), cholesterol could increase the amount and/or
stability of the a-helical conformation, probably as a conse-
quence of a cholesterol-promoted increase in the thickness
of membranes. Other data (31) also support the concept
that native and recombinant SP-C interact similarly with
membranes containing cholesterol, suggesting that the
differences observed in this study with respect to surface
behavior are only manifested once the lipid-protein
complexes are subjected to high lateral pressures during
compression of the interface.
Fig. 7 shows a model that illustrates how palmitoylation
could facilitate SP-C-promoted stabilization of compressed
states in cholesterol-containing surfactant films. Previous
studies have shown that palmitoylation is crucial for SP-C
to remain associated with lipid films subjected to high
compression (32). At the most compressed states, certain
regions of surfactant films likely have properties of a solid-
like condensed phase in the absence of cholesterol, or more
similar to a liquid-ordered phase in the presence of choles-
terol. The partial fluidity of liquid-ordered regions could
impart a highly dynamic character (14) particularly favor-
able to facilitate dynamics of the film upon compression/
expansion cycling, but it would make the film more unstable
at the high pressures than an actual solid phase.
We propose that SP-C-promoted association of surfactant
bilayers with highly packed liquid-ordered regions would
provide additional stability to the multilayered interfacial
film at the end of expiration, and that palmitoylation would
be required for SP-C to sustain association with ordered
phases compressed to their most condensed state, precluding
their out-of-plane relaxation (21). In the absence of palmitoy-
lation, SP-C could still associate with bilayers and mono-
layers, and therefore contribute to promote lipid transfer,
but could not maintain association with the maximally
compressed states of the interfacial film, which would then
become intrinsically unstable and could partially collapse
before reaching maximal pressures (minimal tensions).Biophysical Journal 99(10) 3234–3243
FIGURE 7 Model for the role of palmitoylation
of SP-C in surfactant film stability.
3242 Baumgart et al.The difference between the effects of palmitoylated and non-
palmitoylated SP-C could be more evident in the presence of
cholesterol because, in its absence, the solid character of
condensed patches could provide enough stability even in
the absence of tight bilayer-monolayer contacts.
Overall, our results suggest that optimization of new clin-
ical surfactants may require the defined combination of
proper versions of surfactant proteins. Nonpalmitoylated
forms of SP-C produced in bacteria may be useful as a basis
to produce relatively simple surfactant preparations, with
good surface activity under basic conditions. However,
surfactants containing deacylated SP-C may not be efficient
enough under more demanding conditions, such as those
potentially existing in the airways of patients suffering of
ARDS or other pathologies, where an excess of cholesterol
may constitute an insuperable challenge.SUPPORTING MATERIAL
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